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OBJECTIVES: To illustrate the relationships among sensitivity/specificity, disease
prevalence and PPV/NPV, and demonstrate the impact on model results when
disease prevalence is not considered. METHODS: Using the literature on the sen-
sitivity and specificity of single-photon emission computed tomography (SPECT)
and positron emission tomography (PET) for detecting coronary artery disease as
an example, we derive the PPV/NPV taking prevalence into account. Then we de-
rive the rate of FN and FP from the reported mean sensitivity/specificity as well as
from the varying PPV/NPV. RESULTS:Mean sensitivity and specificity for PET were
0.9 and 0.83, with associated FN and FP of0.1 and 0.17. When using PPV/NPV to
derive FN and FP, FN ranged from 0.05 to 0.22 when prevalence varied from 0.3 to
0.7, while FP ranged from 0.31 to 0.07. Sensitivity and specificity for SPECT were
reported as 0.85 and 0.72,with associated FNand FP of 0.15 and 0.28. Using PPV/NPV
and a prevalence range from 0.3 to 0.7, FN varied from 0.08 to 0.33 and FP varied
from 0.43 to 0.12. CONCLUSIONS: Models results can be significantly biased if
prevalence is not taken into accountwhen deriving FN and FP for economicmodels
of diagnostic accuracy.
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COLONOSCOPY
Anastassopoulos KP, Knight TG, Baik R
Covance Market Access Services, Inc., Gaithersburg, MD, USA
OBJECTIVES:The objective of this studywas to compare estimates fromsurvey and
claims data sources for a low-volume procedure within a specialty population
(specifically, the annual number of inpatient colonoscopies performed in the
United States (US) pediatric population with private insurance) to better under-
stand the considerationswhen choosing a data source.METHODS:A retrospective
analysis of US health insurance claims and national survey data was performed
using Thomson Reuters MarketScan® Commercial Claims and Encounters Da-
tabase (MarketScan®), the National Hospital Discharge Survey (NHDS), and the
National Healthcare Cost and Utilization Project Kids’ Inpatient Database (KID).
Estimates among the privately-insured were obtained overall and by age (0 to 17
years), using ICD-9-CM procedure code 45.23 for calendar year 2007 in Market-
Scan® and NHDS and 2006 in KID (2007 data not available). RESULTS:The overall,
annual estimate of inpatient, privately-insured pediatric colonoscopies was
similar between NHDS and MarketScan®; however, NHDS estimates were not
statistically reliable and differed dramatically from the prior year (overall esti-
mate was 5.6 times higher than 2006). The overall estimate from MarketScan®
was approximately 4.3 times higher than KID with estimates by age also higher;
2.8 times for age 1 to 4.2 times for age range 15-17. The KID database reported
that approximately 50% of colonoscopies were performed in pediatric hospitals.
CONCLUSIONS: The estimates weremarkedly different betweenMarketScan® and
KID, and were not statistically reliable in NHDS. Low representation of pediatric
hospitals that perform a large number of colonoscopies in this population possibly
led to inconsistent or underestimated projections in NHDS and KID, respectively.
Researchers should be informed about the frequency of the procedure of interest
and representativeness of the population in the data when selecting a data source.
Further research is warranted with other low-volume procedures performed in
specialty populations to substantiate these findings.
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OBJECTIVES: Over the last two decades, catheter ablation (CA) has revolutionized
the treatment of pediatric tachycardia by providing a relatively safe alternative to
open-heart surgery or lifelong pharmacotherapy. Despite its high success rate,
however, CA has some risk of major complications, such as complete or second-
degree atrioventricular block, and a higher risk of minor complications, such as
hematoma. No study to date has estimated national frequencies and costs for CA
and its complications in children. The objectives were to 1) determine the fre-
quency of CA; 2) determine the extent ofmajor andminor complications associated
with CA; 3) estimate the average cost and length of stay (LOS) for children under-
going CA; and 4) predict the likelihood ofmajor complications based on patient and
hospital characteristics. METHODS: Data were obtained from the Kids’ Inpatient
Database (KID) for the years 2000, 2003, and 2006. Discharges were selected if CA
(ICD-9 code 37.34) was listed as a primary or secondary procedure. Costs were
computed using the KID cost-to-charge ratios. Logistic regression was used to pre-
dict the odds of major complications. RESULTS: In 2000, there were 1977 pediatric
CAs; in 2003, there were 2049; and, in 2006, 2254. CAs involving children 0-11
months old increased 2.8 fold between 2000 and 2006. The percentage of visits
involving CA complications ranged from 5.56% in 2000 to 7.72% in 2006. In 2006, the
mean cost and mean LOS for visits with CA were $19,425($1,022) and 2.39(0.2)
days, respectively. The odds of major complications from CA for atrial tachycardia
were twice (p0.01) that of supraventricular tachycardia. CONCLUSIONS: In 2006,
the national inpatient cost of CA and its complications totaled $43,783,950. Since
major complications are significantly more likely in young children (up to 6 years
old), caution is required as more such procedures are performed in this age group.
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OBJECTIVES: Bariatric surgery for the treatment of obesity and its underlying co-
morbid conditions is a well-tolerated and safe procedure. While a surgical ap-
proach is becoming the recommendedmethod of treatment formorbid obesity, not
all patients experience significant improvement. The objectives of this study were
to utilize the GE Centricity electronic medical records (EMR) database to perform a
retrospective cohort analysis on weight loss over time in patients with a record of
having laparoscopic gastric banding or bypass surgery to identify predictors of
weight loss following bariatric surgery. METHODS: Analyzable patient records
were drawn from the GE Centricity database from January 1990 through March
2010. To be eligible for inclusion, patients had a recorded CPT Procedure Code of
43644/43645 or 43770; 18 years of age; and a valid recorded BMI within 6 months
prior to procedure and at least one time point post surgery. Univariate and multi-
variable analyses were performed using SAS version 9.2. RESULTS: There were
some notable pre-surgery differences between bypass and band cohorts, including
age,weight, BMI, selected comorbid conditions anduse of antidepressants. Patients
with pre-op BMI values of less than 30 did not experience sustained weight loss, on
average, regardless of surgery type. Patients with pre-surgery BMI values of 30 to less
than35 faredbetterwithbanding (20%BMI loss) thanwithbypass (5%BMIgain) at 2
years post surgery. Finally, patients with pre-surgery BMI values of 35 and above had
greater success, on thewhole, with bypass surgery.CONCLUSIONS: The percent BMI
loss over time by four cohorts of pre-surgery BMI show a trend that may be useful
in predicting treatment success as defined by weight loss. This analysis of EMRs
demonstrates potential clinical benefits when evaluating laparoscopic gastric by-
pass and banding in a real world setting.
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OBJECTIVES: This study is aimed to provide evidence for clinical effectiveness and
stability after Laser in situ keratomilieusis(LASIK) and surface ablation surgery
(LASEK: Laser-Assisted Subepithelial Keratectomy, PRK: photorefractive keratoec-
tomy) for myopia in Korea.METHODS:We searched electronic database including
Ovid-Medline, EMBASE, the Cochrane Library and Korean domestic database such
as Kmbase, Korea Med, NDSL, Kisti, KISS, and KJO(Journal of The Korean Ophthal-
mological Society). Two independent reviewers extracted data and assessed the
quality using MINORS (Methodological index for Non-Randomized Studies). The
changes of UCVA(uncorrected visual acuity) and manifest refractive from pre-sur-
gery were estimated using the random-effect model. Cochrane-Q-statistic and I2-
statistic were used to assess heterogeneity. Subgroup analyses were performed by
length of follow-up(from 24month to 84 month)and myopia degree under-6D(di-
opter) and over-6D. RESULTS: Fifteen observational studies were included formeta
analysis and all study patientswereKorean. After LASIK surgery, compare to before
surgery, UCVA was improved 0.5 decimal in high myopia group(95% CI: 0.20-0.70).
According to subgroup analysis in high myopia group, the group of 6D-10D
UCVA was improved 0.63 decimal, the group of over 10D was improved 0.27
decimal. Also, after surface ablation surgery, UCVA change in high myopia
group(over 6D) was 0.83 decimal and in mild myopia group(under 6D) was 0.61
decimal. In addition to UCVA change was decreased over follow up time. However,
after surface ablation surgery manifest refractive change was 7.45 diopter in high
myopia and 4.00 diopter inmildmyopia group. Also, over follow up time, refractive
change was decreased. CONCLUSIONS: This study provides the evidence that
UCVA was decreased according to over time and in high myopia group. Also, Re-
fractive change was fallen down in compliance with over time, but increased in
high myopia group. Our study is the first one to evaluate clinical effectiveness and
stability of LASIK and surface ablation surgery in Korea through systematic review.
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OBJECTIVES: This study quantifies the benefits of surgeon’s volume on outcomes
in lung surgery: lobectomies and wedge resections. The goal of this analysis is to
analyze the effect of technique-specific experience (VATS) on cost, utilization and
adverse events.METHODS:This study utilizes the Premier hospital databasewhich
contains clinical and utilization information on patients receiving care in over 600
US hospitals. Eligible patients were those of any age undergoing lobectomy or
wedge resection using VATS for cancer treatment. Volume measures use addi-
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